iRhythm Technologies, Inc.

At iRhythm, bold ideas and fast action fuel our impact. Congratulations to Codie Bourn, our Heartbeat Hero for the value Think Big, Go Fast. Codie combines creativity with urgency—driving innovation, breaking barriers, and delivering meaningful results for patients and colleagues. His vision and momentum inspire us all to move quickly and think beyond limits. Thank you, Codie, for leading with ambition, agility, and courage—and for helping propel iRhythm forward.

#ZioByiRhythm #HRX2025 #Cardiacinnovation #Electrophysiology #Cardiology #MedTech #FutureofCare #DigitalHealth

Exciting news as we recognize National Atrial Fibrillation Awareness Month. Oxford University-led AMALFI randomized clinical trial results, presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the Journal of the American Medical Association (JAMA), demonstrate that home-based monitoring with the Zio long-term continuous monitoring (LTCM) service led to increased atrial fibrillation (AFib) detection and a shorter time to diagnosis compared with usual care. “Atrial fibrillation can be difficult to detect as it often occurs without symptoms or infrequently. New technology enables home-based, longer-duration monitoring that can identify episodes which might otherwise be missed,” said Louise Bowman, Professor of Medicine and Clinical Trials at Oxford Population Health and co-author of the study. AFib is a common but often undiagnosed heart rhythm disorder that substantially increases the risk of stroke, heart failure, cardiovascular hospitalization, and health care utilization, making early detection and timely treatment vital to reduce stroke risk, ensure heart rate control, and restore normal sinus rhythm. Learn more here: https://bit.ly/4lYFRYj #ESC2025 #AFib #Cardiology #Arrhythmia #iRhythmTechnologies #Zio #JAMA #digitalhealth

Exciting news as we recognize National Atrial Fibrillation Awareness Month. Oxford University-led AMALFI randomized clinical trial results, presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the Journal of the American Medical Association (JAMA), demonstrate that home-based monitoring with the Zio long-term continuous monitoring (LTCM) service led to increased atrial fibrillation (AFib) detection and a shorter time to diagnosis compared with usual care. “Atrial fibrillation can be difficult to detect as it often occurs without symptoms or infrequently. New technology enables home-based, longer-duration monitoring that can identify episodes which might otherwise be missed,” said Louise Bowman, Professor of Medicine and Clinical Trials at Oxford Population Health and co-author of the study. AFib is a common but often undiagnosed heart rhythm disorder that substantially increases the risk of stroke, heart failure, cardiovascular hospitalization, and health care utilization, making early detection and timely treatment vital to reduce stroke risk, ensure heart rate control, and restore normal sinus rhythm. Learn more here: https://bit.ly/4lYFRYj #ESC2025 #AFib #Cardiology #Arrhythmia #iRhythmTechnologies #Zio #JAMA #digitalhealth

At iRhythm, solving for the patient isn’t just a goal—it’s our purpose. Congratulations to Charlotte Lewis, our Heartbeat Hero for the value Solve for the Patient. Charlotte puts patients first in everything she does. With compassion and dedication, she ensures every action drives better outcomes and greater impact. Her commitment to quality and care inspires us all to keep our mission front and center. Thank you, Charlotte, for leading with purpose and showing us what it truly means to solve for the patient.

#ZioByiRhythm #HRX2025 #Cardiacinnovation #Electrophysiology #Cardiology #MedTech #FutureofCare #DigitalHealth

Thank you, #ESCCongress! It was a privilege to connect with so many engaged professionals and leaders at IFEMA Madrid. To everyone who visited Stand E240, participated in great discussions, and shared your experiences—thank you for making ESC 2025 an inspiring experience. A special thanks to the organisers and community for advancing cardiovascular care and enabling valuable global collaboration. We look forward to continuing the conversations started in Madrid. If you missed us or want to keep in touch, feel free to reach out! https://bit.ly/4fAJTEu #Cardiology #iRhythm #ZioByiRhythm #DigitalHealth #ThankYou #ESCCongress2025 #Madrid

Need to reduce staff burden? EHR integration is available through Epic Aura. Learn more. https://bit.ly/431nURj

At iRhythm, integrity isn’t just what we say—it’s how we lead. Congratulations to Rico Crater, our Heartbeat Hero for the value Lead with Integrity. Rico leads with honesty, accountability, and transparency—always doing the right thing, even when it’s hard. His example earns trust and inspires those around him to follow. Thank you, Rico, for showing us what it means to lead with integrity and for strengthening the culture that makes iRhythm thrive.

It’s Day 1 at #ESCCongress in IFEMA Madrid and our team is ready to welcome you at Stand E240. - Hear the latest in real-world clinical evidence - See how advanced AI is driving streamlined diagnostics - Explore what’s new with Zio technology We look forward to productive conversations with clinicians, innovators, and healthcare leaders. See you at Stand E240! https://bit.ly/4fAJTEu #ESCCongress #Cardiology #iRhythm #ZioByiRhythm #DigitalHealth #Madrid